HPV Prevalence in Transpersons - a Prospective Study

Sophie Pils

Status: Completed

Conditions: Transsexualism; Papillomavirus Infection

Treatments: Diagnostic Test: Colli-Pee urine collection device; Other: Survey

Study type: Interventional

Funder types: Other

Identifiers

NCT04864951

1186/2021

Details and patient eligibility

About

In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orientation, which is adapted from the largest published study.

Full description

All transpeople who visit the outpatient clinic are asked to participate in the study. After being informed and signing the Informed Consent Form, the subjects are asked to give first-void urine and fill out the survey. The urine samples are sent pseudonymously to the University of Ljubljana for analysis. The subjects will be informed about their results within 3 weeks.If the result is positive, the subjects will be offered voluntary further care in our HPV outpatient clinic. However, this will take place outside the study. The data collected there can be used for further analyses.

Enrollment: 203 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Transpeople
• Age over 18 years
• Sufficient knowledge of German

Exclusion criteria

• Age under 18 years
• Insufficient knowledge of German

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

203 participants in 1 patient group

Transpeople

Other group

Description:

1x urine sampling for HPV analysis 1x survey

Treatment:

Other: Survey

Diagnostic Test: Colli-Pee urine collection device